Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suraxavir marboxil vs oseltamivir in uncomplicated influenza (>=12 years)
ChiCTR2500107935Phase 4Not yet recruiting
- Sponsor
- Beijing Ditan Hospital
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of suraxavir marboxil in Influenza A infection and influenza B (2 arms), sponsored by Beijing Ditan Hospital. Primary endpoints: Time to alleviation of influenza symptoms (TTAS), Time to fever resolution and 1 more. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
suraxavir marboxil
03
Conditions
Influenza A infectioninfluenza B
Beyond the preview
Go deeper on ChiCTR2500107935.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500107935.